MOHAN K. RAIZADA, PhD
Department of Physiology and Functional Genomics,
University of Florida College of Medicine, Gainesville, FL
JULIAN F. R. PATON, PhD
SERGEY KASPAROV, MD, PhD
Department of Physiology, School of Medical Sciences,
University of Bristol, Bristol, UK
MICHAEL J. KATOVICH, PhD
Department of Pharmacodynamics, University of Florida College of Pharmacy,
999 Riverview Drive, Suite 208
Totowa, New Jersey 07512
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher.
The content and opinions expressed in this book are the sole work of the authors and editors, who have warranted due diligence in the creation and issuance of their work. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences arising from the information or opinions presented in this book and make no warranty, express or implied, with respect to its contents. Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information
published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication.
Production Editor: Amy Thau
Cover design by Patricia F. Cleary
Cover Illustration: Figure 4A and B from Chapter 13, "Application of Viral Gene Transfer in Studies of Neurogenic Hypertension," by Sergey Kasparov, A. G. Teschemacher, and Julian F. R. Paton. For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers.
This publication is printed on acid-free paper. ∞
ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials. Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $25.00 is paid directly to the Copyright Clearance Center at 222
Rosewood Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is: [1-58829-400-5/05 $25.00].
Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1 eISBN: 1-59259-883-8
Library of Congress Cataloging-in-Publication Data Cardiovascular genomics / edited by Mohan K. Raizada ... [et al.]. p. ; cm. -- (Contemporary cardiology)
Includes bibliographical references and index. ISBN 1-58829-400-5 (hardcover : alk. paper)
1. Cardiovascular system--Diseases--Genetic aspects.
2. Genomics. I. Raizada, Mohan K. II. Series: Contemporary cardiology (Totowa, N.J. : Unnumbered) [DNLM: 1. Cardiovascular Diseases--genetics. 2. Cell Transplantation.
3. Gene Therapy. 4. Gene Transfer Techniques. WG 120 C267475 2005]
RC669.9.C354 2005 616.1'042--dc222004012489